The influence of cyclophosphamide on antitumor immunity in mice bearing late-stage tumors
✍ Scribed by Filip Čulo; Ivica Klapan; Toni Kolak
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 884 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Intraperitoneal (i. p.) treatment of MOPC104E ascitic tumor‐bearing BALB/c mice with interleukin‐1 (IL‐1) followed by a low dose of cyclophosphamide (CPA) resulted in synergistic prolongation of their survival time. This antitumor effect was abolished when administration of CPA preceded
## Abstract The evolution of the specific cell‐mediated immune status was studied in C57BL/6 mice bearing a chemically induced syngeneic sarcoma, the TBL CL2 tumor. Peritoneal cells (PC) as the source of immunocompetent cells were repeatedly harvested from the same groups of mice checked in the in
## Abstract The effects of cyclophosphamide (CY) on tumor immunity against isografts of rat sarcomas induced by polyoma virus were studied using in vitro techniques. Groups of sarcoma‐bearing animals received CY (250 mg/kg intraperitoneally 11 days after isografting) CY (150 mg/kg IP 8 days after i